AzTrials
AzTrials

Postoperative DeliriumNCT04483596

Melatonin to Decrease the Incidence of Postoperative Delirium in Geriatric Patients

An observational study of Postoperative Delirium, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

POD has been reported to be associated with a large number of risk factors: age as POD occurs in 10% to 61% of those aged 65 or older, dementia, impaired left ventricular function, electrolyte disorder, alcoholism, smoking, high perioperative transfusion requirements, intraoperative pressure fluctuation, and use of… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Postoperative Delirium
What is being tested?
melatonin effect on the Abbreviated Mental Test
Type of treatment
Pill or oral medicine
How many people
100 participants
Where
1 siteEgypt
Study dates
30 Jul 2020to 3 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Older adult

Study population: geriatric patients undergoing surgeries under general anesthesia

Who may be able to join

  • ASA physical status I-II

Who cannot join

  • ASA physical status ≥ III.
  • Allergy to the study drugs or one of their ingredients
  • Patients with Abbreviated Mental Test (AMT) score of< 6 ,
  • illiterate people,
  • preoperative sedation score >4,
  • History of alcohol abuse,
Show all 12Show fewer
  • Sensory impairment (blindness, deafness),
  • Severe anemia (hematocrit<27%),
  • Intracranial events (stroke, bleeding, infection),
  • Fluid or electrolyte disturbances including dehydration, hyponatremia, hypernatremia,
  • Acute cardiac events: myocardial infarction, congestive heart failure exacerbation, arrhythmia,
  • Acute pulmonary events: asthma or chronic obstructive pulmonary disease exacerbation, pulmonary embolism, hypoxemia, hypercarbia -,Medications Anticonvulsants, Antidepressants, Antihistamines, Antiparkinsonian agents, Antipsychotics. And history of chronic sedative hypnotic use >3 times/week during a month prior to surgery

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University hospitals

    Cairo, Manial, 12511

Other trials in Egypt

About this study

Official title: Efficacy of Prophylactic Melatonin to Decrease the Incidence of Postoperative Delirium in Geriatric Patients Undergoing Surgeries Under General Anesthesia. A Randomized Controlled Trial.

POD has been reported to be associated with a large number of risk factors: age as POD occurs in 10% to 61% of those aged 65 or older, dementia, impaired left ventricular function, electrolyte disorder, alcoholism, smoking, high perioperative transfusion requirements, intraoperative pressure fluctuation, and use of benzodiazepine POD occurs mostly in some types of surgery, such as orthopedic surgeries, major gastrointestinal surgery, and major cardiovascular surgeries, surgery under general anesthesia, prolonged surgery, emergency surgery

Previous studies done before to prove the efficacy of melatonin to decrease the incidence of postoperative delirium in patients with multiple risk factors for POD as traumatic geriatric patients were concerned only with the type of surgery as hip replacement or with spinal anesthesia but no study was done before to assess the prophylactic effect of melatonin to decrease the incidence of postoperative delirium in geriatric patients under general anesthesia ,which represents an independent risk factor for POD. So,this double blinded RCT will try to fill this gap in literature.

Read the detailed description

POD has been reported to be associated with a large number of risk factors: age as POD occurs in 10% to 61% of those aged 65 or older, dementia, impaired left ventricular function, electrolyte disorder, alcoholism, smoking, high perioperative transfusion requirements, intraoperative pressure fluctuation, and use of benzodiazepine POD occurs mostly in some types of surgery, such as orthopedic surgeries, major gastrointestinal surgery, and major cardiovascular surgeries, surgery under general anesthesia, prolonged surgery, emergency surgery

Previous studies done before to prove the efficacy of melatonin to decrease the incidence of postoperative delirium in patients with multiple risk factors for POD as traumatic geriatric patients were concerned only with the type of surgery as hip replacement or with spinal anesthesia but no study was done before to assess the prophylactic effect of melatonin to decrease the incidence of postoperative delirium in geriatric patients under general anesthesia ,which represents an independent risk factor for POD. So,this double blinded RCT will try to fill this gap in literature.

Aim of the study:

To prove the efficacy of melatonin to decrease the incidence of postoperative delirium after surgeries under general anesthesia in geriatric patients.

Methodology After approval of the Research Ethics Committee and written informed consent from all patients, A randomized, prospective, controlled, double blind study of the prophylactic effect of melatonin on postoperative delirium in geriatric patients undergoing surgeries under general anesthesia will be conducted on 100 patients allocated into 2 equal groups. The study will be conducted at Cairo University Hospitals, in all surgical units.

Randomization: Patients who meet all the inclusion criteria will be randomized to either Group M (Melatonin group) or Group C (Control group) by using computer generated random numbers with closed sealed envelope.

All patients will fast according to standard rules and will be assessed by an anesthesiologist at the night before the surgery.

All patients will be screened at that time by Abbreviated Mental Test (AMT) ,where patients having scores < 6 will be considered to have postoperative delirium.This test has been recommended for routine assessment of cognitive function in the elderly by the Royal College of Physicians and the British Geriatric Society.

Questionnare (score) Each scores one point

  1. Age
  2. Time (to nearest hour)
  3. Address for recall at end of test (Ask patient to repeat the address to ensure it has been heard correctly)
  4. Year
  5. Name of hospital
  6. Recognition of two persons (e.g. doctor, nurse)
  7. Date of birth
  8. Year of any famous event e.g: the last Egyptian revolution
  9. Name of the present monarch
  10. Count backwards from 20 to 1

Group M (Melatonin group): will receive 5 mg melatonin orally at 9 p.m. the night before surgery and another 5 mg melatonin with 15 ml of plain water 30 min before operation and 5 mg melatonin at 9 p.m. in the day of operation and for the first three postoperative days.

Group C (Control group): received a placebo in the form of one tablet of 500 mg paracetamol that packaged the same way as melatonin at the same times.

The anesthesia residents who will administer the drug and assess Abbreviated Mental Test(AMT) score postoperatively will be blinded to the allocation regimen.

On arrival to the preparation room, wide bore IV cannula will be inserted in the nondominant hand, sedation will be assessed by Ramsay sedation scale,with grades from 1 to 6 where:1-Patient awake, anxious, agitated, or restless ,2- Patient awake, cooperative, orientated, and tranquil ,3- Patient drowsy, with response to commands ,4- Patient asleep, brisk response to glabella tap or loud auditory stimulus ,5- Patient asleep, sluggish response to stimulus ,6- Patient has no response to firm nail-bed pressure or other noxious stimuli. patients with score > 4 will be excluded from the study.

All Patients will be monitored with five lead ECG, noninvasive blood pressure, oxygen saturation, capnography and baseline HR,SBP,DBP,MAP,oxygen saturation,ETCO2 , and urine output will be recorded then every 10 minutes until 30 minutes postextubation. Induction of anesthesia will be done with fentanyl (2 mic/kg), propofol (1-2 mg/kg), atracurium (0.5 mg/kg). Intubation will be done with oral cuffed endotracheal tube size 6.5-7 mm ID for females and 7.5-8 mm ID for males and then a urinary catheter will be inserted. Anesthesia will be maintained with isoflurane (0.75- 1.15%), incremental doses of atracurium every 20 minutes and 1 mic/kg fentanyl IV if HR and/or BP increased 20% or more from baseline in response to surgical stimulation.

After surgery, patients will be transferred to PACU. Abbreviated Mental Test (AMT) scores will be reported after recovery from anesthesia (PACU AMT) and in the same day 6 hours after operation (Day-0) and in the following three postoperative days (Day-1, Day-2 and Day-3) at the same hour of assessment in day 0. Patients having scores < 6 will be considered to have postoperative delirium, and will be assessed by a psychiatrist for further management.

Postoperative pain will be managed by IV 1g paracetamol every 6 hours and 50 mg diclofenac sodium oral every 12 hours with rescue analgesia of IV nalbuphine with 0.25 mg/kg not exceeding 0.5 mg/kg every 6 hours when the numerical rating score (NRS) or advanced dementia scale (PAINAD)(if the patient developed delirium) >4.NRS or PAINAD will be evaluated according to at times 0-30 minutes 2, 4,8, 12, 18 and 24 hours. The "zero" point of time will be the moment the patient recovered from general anesthesia

Being tested
melatonin effect on the Abbreviated Mental Test
Keywords
melatonin, delirium, geriatrics, general anesthesia
Medical subject headings
Emergence Delirium, Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • melatonin effect on the Abbreviated Mental TestDrug

    Questionnare

    1. Age
    2. Time (to nearest hour)
    3. Address for recall at end of test (Ask patient to repeat the address to ensure it has been heard correctly)
    4. Year
    5. Name of hospital
    6. Recognition of two persons (e.g. doctor, nurse)
    7. Date of birth
    8. Year of any famous event e.g: the last Egyptian revolution
    9. Name of the present monarch
    10. Count backwards from 20 to 1
Study groups in NCT04483596
Study groupRoleWhat they receive
Mwill receive 5 mg melatonin orally at 9 p.m. the night before surgery and another 5 mg melatonin with 15 ml of plain water 30 min before operation and 5 mg melatonin at 9 p.m. in the day of operation and for the first three postoperative days
Receives: Drug: melatonin effect on the Abbreviated Mental Test
Creceived a placebo in the form of one tablet of 500 mg paracetamol that packaged the same way as melatonin at the same times
Receives: Drug: melatonin effect on the Abbreviated Mental Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative delirium

    Detection of the difference in incidence of POD between melatonin group and control group using the Abbreviated Mental Test (AMT)

    Measured: 3 postoperative days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2020
  2. Study start30 Jul 2020
  3. Primary completion1 Dec 2020
  4. Study completion3 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04483596
Sponsor's protocol ID
MS-103-2020
Status last verified
Dec 2020
First submitted
20 Jul 2020
Last updated
22 Dec 2020
Results posted
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No: not to share

Publications

  • 1. Gray SL, Lai KV, Larson EB. Drug induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999;(21):101-22. 2. Guo Y, Jia P, Zhang J, Wang X, et tal. Prevalence and risk factors of postoperative delirium in elderly hip fracture patients. J Int Med Res. 2016;44(2):317-327. 3. Parikh SS, Chung F. Postoperative delirium in the elderly. Anesth Analg 1995;(80):1223-32. 4. Jankowski CJ, Trenerry MR, Cook DJ, et al. Cognitive and functional predictors and sequelae of postoperative delirium in elderly patients undergoing elective joint arthroplasty. Anesth Analg 2011;(112):1186-1193.

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Delirium, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative delirium (time frame: 3 postoperative days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04483596, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2020; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in